Data is currently being updated. Some features may be temporarily unstable.

Disease Profile

Viral

Respiratory syncytial virus infection (RSV)

呼吸道合胞病毒感染

Respiratory syncytial virus (RSV) infection is a viral respiratory infection identified in the source material as a public-health encyclopedia topic and as the human orthopneumovirus associated with respiratory illness [1][2]. The available evidence here is limited and largely bibliographic, so the profile should be read conservatively as a source-bound surveillance note rather than a full clinical monograph [1][3]. Source-backed detail on epidemiologic burden, transmission specifics, and prevention measures is not yet available in the provided snippets [1][3].

Definition

Respiratory syncytial virus (RSV) infection is a viral disease entity referenced in scholarly and public-health literature, including an entry in the Encyclopedia of Public Health [1]. The source material also identifies human respiratory syncytial virus as the orthopneumovirus that specifically affects infants and small children [2]. Beyond this general etiologic characterization, the provided snippets do not supply a fuller disease definition or laboratory classification [1][2].

Clinical features

The available source text indicates that orthopneumoviruses can produce respiratory illness ranging from less severe upper-respiratory disease to severe bronchiolitis or pneumonia [2]. One source title links RSV infection with wheezing, which supports wheezing as a clinically relevant association in the literature, but the snippet does not provide a detailed symptom description [4]. Source-backed detail on incubation period, duration, complication frequency, or severity distribution is not yet available in the provided material [1][4][2].

Epidemiology

The source material states that orthopneumoviruses are found among sheep, cows, and humans, and that human RSV is the orthopneumovirus specifically impacting infants and small children [2]. This establishes a host range across species and a recognized human pediatric focus, but it does not provide incidence, seasonality, outbreak history, geographic distribution, or burden estimates [2]. The remaining sources are scholarly metadata only and do not add epidemiologic detail beyond publication context [1][4][3][5].

Transmission

The provided snippets do not state a transmission route, exposure mechanism, or environmental persistence for RSV infection [1][3][2]. Because the evidence boundary is limited to metadata and high-level taxonomy, route-specific statements would be speculative and are omitted here [1][2]. Source-backed detail on person-to-person spread, droplet transmission, contact exposure, or other mechanisms is not yet available [1][3].

Risk groups

The only explicitly supported risk group in the provided snippets is infants and small children, identified as the human population specifically impacted by RSV [2]. No additional risk strata, such as pregnancy, older age, chronic disease, prematurity, or immunocompromise, are stated in the supplied sources and therefore are not added here [2].

Prevention

One source is explicitly concerned with preventing RSV infection, indicating that prevention is a recognized topic in the literature [3]. However, the snippet does not describe any specific measures, target populations, or intervention schedule, so no particular prevention strategy can be stated from the provided evidence [3]. Source-backed detail on immunization, prophylaxis, isolation, hygiene, or environmental control is not yet available [3].

Surveillance note

For surveillance purposes, this record should be interpreted as a conservative RSV respiratory-infection concept anchored in source metadata and broad disease classification rather than a fully characterized case definition [1][2]. The strongest source-supported signals are its association with respiratory illness and with wheezing, plus its relevance to infants and small children [4][2]. Monitorers should note that the provided material does not include operational case criteria, confirmatory testing language, or epidemiologic thresholds [1][4][3].

References
  1. 1 Respiratory-Syncytial-Virus (RSV) Infection. Encyclopedia of Public Health. 2008. doi: 10.1007/978-1-4020-5614-7_3016. DOI: https://doi.org/10.1007/978-1-4020-5614-7_3016
  2. 2 Wikipedia contributors. Orthopneumovirus [Internet]. Wikipedia. cited 20 May 2026. Available from: https://en.wikipedia.org/wiki/Orthopneumovirus
  3. 3 PREVENTING RESPIRATORY SYNCYTIAL VIRUS (RSV) INFECTION. Advances in Neonatal Care. 2005. doi: 10.1016/j.adnc.2004.10.006. DOI: https://doi.org/10.1016/j.adnc.2004.10.006
  4. 4 Respiratory syncytial virus (RSV) infection and wheezing. Wheezing Disorders in the Pre-School Child. 2003. doi: 10.3109/9780203624340-3. DOI: https://doi.org/10.3109/9780203624340-3
  5. 5 Respiratory Syncytial Virus (RSV). Encyclopedic Dictionary of Polymers. 2011. doi: 10.1007/978-1-4419-6247-8_14689. DOI: https://doi.org/10.1007/978-1-4419-6247-8_14689
  6. 6 Wikidata contributors. Respiratory Syncytial Virus Infection in Children [Internet]. Wikidata. cited 20 May 2026. Available from: https://www.wikidata.org/wiki/Q95417215
Coding Register
ICD-10
ICD-11
Key Statistics
Total cases
2.3M
Peak month
2021-07
Coverage
2 reporting countries · 2000-01-01 → 2026-06-20

Figure 1 | Full historical trajectories across all reporting countries.

Figure 2 | Year-over-year monthly comparison for seasonality and structural shifts.

Dataset Archive

Supplementary Data | Multi-country disease dataset

Machine-readable multi-country disease dataset (JSON/CSV) with source metadata.

Rows
1,035
Data Version
2026-06-20
Coverage
Included metadata
Source links, scope, cadence

Source Register

Official sources and update cadences used to construct the downloadable dataset.

AU
Australia NINDSSmonthlymicrosoft_bi

Australia

Australian national notifiable diseases surveillance dashboard.

Official source
JP
JP NIID Weeklyweeklyweb

Japan

Japan weekly infectious disease surveillance via NIID/JIHS.

Official source
Suggested presentation pattern: cite the data version and coverage window when exporting charts or tables for publication.